USP18 and neoplasm: Burkart et al. [69] reported that USP18 deficient mammary epithelial cells created an anti-tumor environment driven by hypersensitivity to IFN-λ and elevated secretion of CXCL-10, a member of the chemokine family induced in a variety of cells in response to INF-γ and lipopolysaccharide.